This page has been archived on the Web
Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.
Equate-Muscle & Back Pain Relief -8 (2016-01-22)
- Starting date:
- January 22, 2016
- Posting date:
- February 2, 2016
- Type of communication:
- Drug Recall
- Subcategory:
- Drugs
- Hazard classification:
- Type III
- Source of recall:
- Health Canada
- Issue:
- Product Safety
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-56956
Affected Products
Equate-Muscle & Back Pain Relief -8
Reason
Product did not meet stability specification for Codeine Phosphate assay.
Depth of distribution
Distributed down to retailers in Alberta, British Columbia, Manitoba, New Brunswick, Newfoundland, Nova Scotia, Ontario, Quebec and Saskatchewan.
Affected products
Equate-Muscle & Back Pain Relief -8
DIN, NPN, DIN-HIM
DIN 02248977
Dosage form
Caplets
Strength
- Methocarbamol 400 mg
- Acetaminophen 325 mg
- Codeine phosphate 8 mg
Lot or serial number
- Lot 656306
- Lot 656307
Companies
- Recalling Firm
-
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA
- Marketing Authorization Holder
-
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA